Galectin-3 levels in children with cystic fibrosis
- PMID: 38430280
- DOI: 10.1007/s00431-024-05479-6
Galectin-3 levels in children with cystic fibrosis
Erratum in
-
Correction to: Galectin-3 levels in children with cystic fibrosis.Eur J Pediatr. 2024 Aug;183(8):3633-3634. doi: 10.1007/s00431-024-05585-5. Eur J Pediatr. 2024. PMID: 38761224 No abstract available.
Abstract
Cystic fibrosis (CF) is a multisystemic disease in which airway obstruction, infection, and inflammation play a critical role in the pathogenesis and progression of CF lung disease. The carbohydrate-binding protein Galectin-3 is increased in several inflammatory and fibrotic diseases and has recently been forwarded as a biomarker in these diseases. We aimed to define the role of serum Galectin-3 in children with CF by comparison with healthy subjects. This is a cross-sectional, case-control study. 143 CF and 30 healthy subjects were enrolled in the study. Peripheral blood and sputum concentrations of Galectins-3, interleukin (IL)-17A, IL-8, and neutrophil elastase (NE) were determined with commercial ELISA kits. There was no significant difference between the groups in age and gender (p = 0.592, p = 0.613, respectively). Serum Galectin-3 and NE concentrations were higher in the patient group than in healthy controls (p = 0.002, p < 0.001, respectively). There were no significant differences between groups according to IL-17A and IL-8 concentrations. Serum Galectin-3 was correlated with age (r = 0.289, p < 0.001) and body mass index (BMI) (r = 0.493, p < 0.001) in children with CF. Sputum Galectin-3 levels are negatively correlated with percent predictive forced expiratory volume in 1 s (FEV1) (r = - 0.297, p = 0.029), FEV1 z-score, (r = - 0.316, p = 0.020), percent predictive forced vital capacity (FVC) (r = - 0.347, p = 0.010), and FVC z-score (r = - 0.373, p = 0.006). Conclusion: The study shows that serum Galectin-3 levels increased in clinically stable CF patients, and serum Galectin-3 response may depend on age, gender, and BMI. The sputum Galectin-3 was found to be negatively correlated with patients' lung functions. What is known: • Galectin-3 is a key regulator of chronic inflammation in the lung, liver, kidney, and tumor microenvironment. What is new: • Children with cystic fibrosis (CF) have higher serum Galectin-3 concentrations than healthy children. • Serum Galectin-3 expression influenced by age, BMI, and gender in children with CF.
Keywords: Cystic fibrosis; Galectin-3; Inflammation; Neutrophil elastase; Pediatrics.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.Clin Exp Immunol. 2021 Sep;205(3):391-405. doi: 10.1111/cei.13624. Epub 2021 Jun 16. Clin Exp Immunol. 2021. PMID: 34031873 Free PMC article.
-
Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.Pediatr Pulmonol. 2005 Mar;39(3):224-32. doi: 10.1002/ppul.20165. Pediatr Pulmonol. 2005. PMID: 15635615 Clinical Trial.
-
Higher Interleukin-7 serum concentrations in patients with cystic fibrosis correlate with impaired lung function.J Cyst Fibros. 2019 Jan;18(1):71-77. doi: 10.1016/j.jcf.2018.09.008. Epub 2018 Oct 31. J Cyst Fibros. 2019. PMID: 30389600
-
Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.Paediatr Drugs. 2005;7(6):353-63. doi: 10.2165/00148581-200507060-00004. Paediatr Drugs. 2005. PMID: 16356023 Review.
-
Galectin-3: action and clinical utility in chronic kidney disease.Int Urol Nephrol. 2024 Nov;56(11):3535-3543. doi: 10.1007/s11255-024-04107-4. Epub 2024 Jun 11. Int Urol Nephrol. 2024. PMID: 38861106 Review.
Cited by
-
Exploring Serum Biomarker Levels in Tetralogy of Fallot, Hypoplastic Left Heart Syndrome, and Healthy Children.Pediatr Cardiol. 2025 Jul 8. doi: 10.1007/s00246-025-03935-0. Online ahead of print. Pediatr Cardiol. 2025. PMID: 40624190
References
-
- Shteinberg M, Haq IJ, Polineni D, Davies JC (2021) Cystic fibrosis. Lancet 397:2195–2211. https://doi.org/10.1016/S0140-6736(20)32542-3 - DOI - PubMed
-
- Nichols DP, Chmiel JF (2015) Inflammation and its genesis in cystic fibrosis. Pediatr Pulmonol 50(Suppl 40):S39-56. https://doi.org/10.1002/ppul.23242 - DOI - PubMed
-
- McElvaney NG, Proteases CRG, lung injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ, (eds) (1997) The lung: scientific foundations. Lippincott-Raven, Philadelphia, PA, pp 2205–2218
-
- Stockley RA (1995) Role of inflammation in respiratory tract infections. Am J Med 99(6B):8S-13S. https://doi.org/10.1016/s0002-9343(99)80304-0 - DOI - PubMed
-
- Chen K, Eddens T, Trevejo-Nunez G et al (2016) IL-17 receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against K. pneumoniae. Cell Host Microbe 20:596–605. https://doi.org/10.1016/j.chom.2016.10.003 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical